← SynDRA
OSI-632
SynDRA canonical compound SYN0008573 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DDR2 | EGFR | FGF2 | KDR |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- KDR INHIBITOR
- Vascular endothelial growth factor receptor 2 inhibitor
- kinase inhibitor
Cross-references
Synonyms
- CP-547,632
- CP-547632
- CP-632
- PAN-90806
- PAN90806
- CP 547632
- BFF
- 3-(4-Bromo-2,6-difluorobenzyloxy)-5-(3-(4-pyrrolidin-1-ylbutyl)ureido)isothiazole-4-carboxylic acid amide
- Cp-547632
- CP 547,632
- CP547632
- W1B375O5M2
- RefChem:919128
- DTXCID60102357
- CP547,632
- Kinome_3755
- C20H24BrF2N5O3S
- UNII-W1B375O5M2
- HXHAJRMTJXHJJZ-UHFFFAOYSA-N
- SCHEMBL187261
- GTPL7881
- orb1709995
- BDBM25115
- GLXC-15617
- EX-A11159
- NSC800077
- AKOS016008145
- NSC-800077
- T10870L
- NCGC00263100-01
- NCGC00263100-02
- NCGC00263100-04
- NCGC00263100-05
- AC-25487
- HY-13302
- MS-29834
- CP-547632?
- CS-0003189
Look up OSI-632 in the interactive SynDRA portal →